Cecile M. Krejsa

2.3k citations

39 papers · 1.8k indexed · 1 hit paper · h-index 19

Molecular Biology top 10%
Pharmacology top 2%
Oncology
Computational Theory and Mathematics top 2%
Immunology

Co-authors: Terrance J. Kavanagh Collin C. White Gary L. Schieven Dianne Botta Nina Kaludercic Dolores Diaz M. R. Slaughter Paolo Bernardi
Topics: Sulfur Compounds in Biology (12 papers)Chronic Lymphocytic Leukemia Research (6 papers)Chronic Myeloid Leukemia Treatments (6 papers)
Cited by: Biochemistry Pharmacology Computational Theory and Mathematics
Journals: Journal of Biological Chemistry Journal of Clinical Oncology Blood
Partner nations: United States Germany United Kingdom

In The Last Decade

Cecile M. Krejsa

37 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening

2006 472 citations Cecile M. Krejsa et al. profile →

Peers

Countries citing papers authored by Cecile M. Krejsa

Since Specialization

Citations

This map shows the geographic impact of Cecile M. Krejsa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecile M. Krejsa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecile M. Krejsa more than expected).

Fields of papers citing papers by Cecile M. Krejsa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecile M. Krejsa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecile M. Krejsa. The network helps show where Cecile M. Krejsa may publish in the future.

Co-authorship network of co-authors of Cecile M. Krejsa

This figure shows the co-authorship network connecting the top 25 collaborators of Cecile M. Krejsa. A scholar is included among the top collaborators of Cecile M. Krejsa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecile M. Krejsa. Cecile M. Krejsa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P1006: CHARACTERIZATION OF TL-895: A NOVEL BRUTON TYROSINE KINASE INHIBITOR (BTKI) IN CLINICAL DEVELOPMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MYELOFIBROSIS (MF) 2023 ·HemaSphere ·Michael Gulrajani,(unknown),Jean Cheung,Fanny Krantz,Cynthia Nguyen,(unknown),Cecile M. Krejsa,(unknown),Todd Covey	1
2	TL-895, a Highly Selective, Covalent Inhibitor of Bruton's Tyrosine Kinase (BTK), Sensitizes Myeloproliferative Neoplasm (MPN)-Blast Phase Stem Cells to Navtemadlin By Targeting Intrinsic Dysregulated MDM2/p53 and NF-Κb Pathways and Disrupting the Protective Tumor Microenvironment (TME) 2023 ·Blood ·Xiaoli Wang,(unknown),Xiaoping Su,Muharrem Müftüoğlu,Cecile M. Krejsa,John Mascarenhas,Michael Andreeff,Ronald Hoffman	0
3	Potential Disease-Modifying Activity of Navtemadlin (KRT-232), a First-in-Class MDM2 Inhibitor, Correlates with Clinical Benefits in Relapsed/Refractory Myelofibrosis (MF) 2021 ·Blood ·(unknown),Andrzej Lange,(unknown),Haifa Kathrin Al‐Ali,Jesús María Hernández‐Rivas,Jean‐Jacques Kiladjian,Alessandro M. Vannucchi,Andrew C. Perkins,(unknown),Cecile M. Krejsa,Anne Uyei,Jesse McGreivy,(unknown),John Mascarenhas,Srđan Verstovšek	17
4	Bridging in vitro dissolution and in vivo exposure for acalabrutinib. Part II. A mechanistic PBPK model for IR formulation comparison, proton pump inhibitor drug interactions, and administration with acidic juices 2019 ·European Journal of Pharmaceutics and Biopharmaceutics ·Xavier Pépin,(unknown),James Mann,(unknown),Richard A. Barker,E. J. Meehan,(unknown),(unknown),(unknown),Cecile M. Krejsa,(unknown),(unknown),J. Greg Slatter	39
5	Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma 2016 ·PLoS ONE ·Bonnie K. Harrington,Heather L. Gardner,Raquel Izumi,Ahmed Hamdy,Wayne Rothbaum,Kevin R. Coombes,Todd Covey,Allard Kaptein,Michael Gulrajani,Bart van Lith,Cecile M. Krejsa,Christopher C. Coss,Duncan S. Russell,Xiaoli Zhang,(unknown),Cheryl A. London,John C. Byrd,Amy J. Johnson,William C. Kisseberth	43
6	An inter-laboratory retrospective analysis of immunotoxicological endpoints in non-human primates: Flow cytometry immunophenotyping 2013 ·Journal of Immunotoxicology ·Cecile M. Krejsa,Moni B. Neradilek,Nayak L. Polissar,(unknown),(unknown),(unknown),Jeanine L. Bussiere,Hervé Lebrec	8
7	An inter-laboratory retrospective analysis of immunotoxicological endpoints in non-human primates: T-cell-dependent antibody responses 2011 ·Journal of Immunotoxicology ·Hervé Lebrec,(unknown),(unknown),Cecile M. Krejsa,Moni B. Neradilek,Nayak L. Polissar,Lauren E. Black,Jeanine L. Bussiere	9
8	B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin 2010 ·Arthritis Research & Therapy ·Stacey R. Dillon,Brandon Harder,Kenneth B. Lewis,Margaret Moore,Hong Liu,Thomas R. Bukowski,Nels Hamacher,(unknown),Mark Maurer,Cecile M. Krejsa,Jeff L. Ellsworth,Susan Pederson,Keith B. Elkon,Mark H. Wener,Maria Dall’Era,Jane A. Gross	81
9	Rapid Activation of Glutamate Cysteine Ligase following Oxidative Stress 2010 ·Journal of Biological Chemistry ·Cecile M. Krejsa,Christopher C. Franklin,Collin C. White,Jeffrey A. Ledbetter,Gary L. Schieven,Terrance J. Kavanagh	82
10	Protein therapeutics: new applications for pharmacogenetics 2006 ·Nature Reviews Drug Discovery ·Cecile M. Krejsa,Mark Rogge,Wolfgang Sadée	66
11	Glutamate-cysteine ligase attenuates TNF-induced mitochondrial injury and apoptosis 2004 ·Free Radical Biology and Medicine ·Dianne Botta,Christopher C. Franklin,Collin C. White,Cecile M. Krejsa,Michael J. Dabrowski,Robert H. Pierce,Nelson Fausto,Terrance J. Kavanagh	42
12	Effect of methylmercury on glutamate-cysteine ligase expression in the placenta and yolk sac during mouse development 2004 ·Reproductive Toxicology ·Dolores Dı́az,Cecile M. Krejsa,Collin C. White,Jay S. Charleston,Terrance J. Kavanagh	9
13	Mechanisms of IL-21 Enhancement of Rituximab Efficacy in a Lymphoma Xenograft Model. 2004 ·Blood ·(unknown),(unknown),Cecile M. Krejsa,Mark Heipel,(unknown),Rick D. Holly,Pallavur V. Sivakumar,Katherine Henderson,(unknown),(unknown),Wayne Kindsvogel,Don Foster	1
14	Detection of Oxidative Stress in Lymphocytes Using Dichlorodihydrofluorescein Diacetate 2003 ·Humana Press eBooks ·Cecile M. Krejsa,Gary L. Schieven	28
15	Fluorescence-based microtiter plate assay for glutamate–cysteine ligase activity 2003 ·Analytical Biochemistry ·Collin C. White,(unknown),Cecile M. Krejsa,Dianne Botta,Terrance J. Kavanagh	250
16	Caspase-3-Dependent Cleavage of the Glutamate-l-Cysteine Ligase Catalytic Subunit during Apoptotic Cell Death 2002 ·American Journal Of Pathology ·Christopher C. Franklin,Cecile M. Krejsa,Robert H. Pierce,Collin C. White,Nelson Fausto,Terrance J. Kavanagh	66
17	Expression of glutamate‐cysteine ligase during mouse development 2002 ·Molecular Reproduction and Development ·Dolores Dı́az,Cecile M. Krejsa,Terrance J. Kavanagh	13
18	Induction of glutamate-cysteine ligase (γ-glutamylcysteine synthetase) in the brains of adult female mice subchronically exposed to methylmercury 1999 ·Toxicology Letters ·Sally A. Thompson,Collin C. White,Cecile M. Krejsa,Dolores Dı́az,James S. Woods,David L. Eaton,Terrance J. Kavanagh	57
19	Impact of oxidative stress on signal transduction control by phosphotyrosine phosphatases. 1998 ·Environmental Health Perspectives ·Cecile M. Krejsa,Gary L. Schieven	36
20	Role of Oxidative Stress in the Action of Vanadium Phosphotyrosine Phosphatase Inhibitors 1997 ·Journal of Biological Chemistry ·Cecile M. Krejsa,Steven G. Nadler,James M. Esselstyn,Terrance J. Kavanagh,Jeffrey A. Ledbetter,Gary L. Schieven	130

About Cecile M. Krejsa

Cecile M. Krejsa is a scholar working on Biochemistry, Genetics and Hematology, having authored 39 papers that have together received 1.8k indexed citations. Recurring topics across this work include Sulfur Compounds in Biology (12 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). The work is most often cited by research in Biochemistry (205 citations), Pharmacology (246 citations) and Computational Theory and Mathematics (211 citations). Cecile M. Krejsa has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Terrance J. Kavanagh, Collin C. White, Gary L. Schieven, Dianne Botta, Nina Kaludercic, Dolores Diaz, M. R. Slaughter, Paolo Bernardi, Peter J. O’Brien and William Irwin. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact